| # | Drug | Count |
|---|---|---|
| 0 | PREDNISOLONE | 32 |
| 1 | PREDNISOLONE ORAL | 32 |
| 2 | PREDNISOLONE ORAL SOLUTION | 32 |
| 3 | ECULIZUMAB | 21 |
| 4 | PREDNISONE | 20 |
| 5 | TACROLIMUS | 13 |
| 6 | METHOTREXATE | 12 |
| 7 | METHOTREXATE SODIUM | 12 |
| 8 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 11 |
| 9 | TACROLIMUS OINTMENT 0.1% | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CLEMASTINE FUMARATE | 4 | 0.0029 |
| 1 | METEX | 1 | 0.0026 |
| 2 | CEFADROXIL | 3 | 0.0015 |
| 3 | PYRIDOSTIGMINE BROMIDE ORAL | 3 | 0.0008 |
| 4 | FOSINOPIRL SODIUM | 1 | 0.0005 |
| 5 | TECLISTAMAB-CQYV | 1 | 0.0004 |
| 6 | AMPICILLIN SODIUM AND SULBACTAM SODIUM | 1 | 0.0004 |
| 7 | ECULIZUMAB | 21 | 0.0004 |
| 8 | ACETAMINOPHEN AND DIPHENHYDRAMINE HCL | 1 | 0.0003 |
| 9 | ACETAMINOPHEN, DEXTROMETHORPHAN HBR | 1 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 56 |
| 1 | Complement Inhibitor [EPC] | 31 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 14 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 11 |
| 4 | HMG-CoA Reductase Inhibitor [EPC] | 8 |
| 5 | Insulin Analog [EPC] | 8 |
| 6 | Alkylating Drug [EPC] | 7 |
| 7 | Azole Antifungal [EPC] | 7 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 7 |
| 9 | General Anesthetic [EPC] | 6 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Complement Inhibitor [EPC] | 31 | 0.0006 |
| 1 | Neonatal Fc Receptor Blocker [EPC] | 1 | 0.0002 |
| 2 | beta Lactamase Inhibitor [EPC] | 1 | 0.0002 |
| 3 | Provitamin D2 Compound [EPC] | 5 | 0.0002 |
| 4 | Lipid-based Polyene Antifungal [EPC] | 2 | 0.0002 |
| 5 | Vitamin D3 Analog [EPC] | 3 | 0.0001 |
| 6 | General Anesthetic [EPC] | 6 | 0.0001 |
| 7 | Glinide [EPC] | 1 | 0.0001 |
| 8 | Lipopeptide Antibacterial [EPC] | 1 | 0.0001 |
| 9 | Pyridone [EPC] | 4 | 0.0001 |